The long-acting GLP-1 receptor agonists segment dominated the market with the largest revenue share of 55.5% in 2024, driven by their superior efficacy in sustained weight loss, cardiovascular benefits, and the convenience of once-weekly dosing
Heise, T., Mari, A., DeVries, J
Where It Stands Today Retatrutide is an investigational weight loss medication (meaning its still being studied) that targets three hunger-regulating hormones
Medical Benefits Beyond Weight Loss Semaglutide doesnt just help shed poundsit improves metabolic health by regulating blood sugar levels, which can lower the risk of Type 2 diabetes
If your appetite is low, focus on high-quality protein during your hungriest time of day